Indication
Indicated for active immunisation of adults against hepatitis B virus (HBV) infection
Loading your page…
Loading your page…
Hepatitis B
Marketing Authorisation Holder: Dynavax International B.V.
AI Drug & Interaction Analysis
Free account required
Ask Osler about Heplisav: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.